Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites

BACKGROUND: Recent circumstantial evidence suggests that an increasing number of Iranian patients with cutaneous leishmaniasis are unresponsive to meglumine antimoniate (Glucantime), the first line of treatment in Iran. This study was designed to determine whether the clinical responses (healing, or...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hadighi, Ramtin, Mohebali, Mehdi, Boucher, Patrick, Hajjaran, Homa, Khamesipour, Ali, Ouellette, Marc
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2006
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1435779/
https://ncbi.nlm.nih.gov/pubmed/16605301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.0030162
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak